Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist under investigation for type 2 diabetes applications. This peptide compound demonstrates superior efficacy in glucose control and weight management compared to existing therapies.
The molecular structure of Tirzepatide (C225H348N48O68) enables unique receptor binding properties, with greater affinity for GIP receptors than GLP-1 receptors. This dual mechanism contributes to its enhanced hyperglycemia reduction capabilities in preclinical studies.
Our research-grade Tirzepatide is supplied as a white powder with guaranteed purity levels exceeding 98%. The compound maintains stability when stored properly at recommended temperatures, with a shelf life exceeding two years under optimal conditions.
Current research indicates Tirzepatide may offer benefits beyond glycemic control, including potential effects on beta-cell preservation and metabolic function. These properties make it a valuable compound for diabetes-related research applications.
For research purposes only. Not intended for human consumption or diagnostic use. Proper handling procedures should be followed by qualified researchers in controlled laboratory environments.
